GTBPVSPECO• 3 Months (Normalized)
GTBP vs PECO (GT Biopharma Inc. vs Phillips Edison & Company Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1144.9%
GT Biopharma Inc.
Normalized Baseline0.00%
PECO Performance $37.76
-9.64%
Phillips Edison & Company Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1154.54 pts
GTBP outperforming by 1154.54 percentage points
GTBPPECO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP PECO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | GTBP Price | GTBP Gain (%) | PECO Price | PECO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1144.90% | $37.76 | -9.64% | +1154.54% |
| Sep 29, 2026 | $6.88 | +1303.06% | $- | - | |
| Sep 28, 2026 | $6.80 | +1287.76% | $37.54 | -10.17% | +1297.93% |
| Sep 25, 2026 | $6.89 | +1306.12% | $37.39 | -10.53% | +1316.65% |
| Sep 24, 2026 | $6.83 | +1293.88% | $37.12 | -11.17% | +1305.05% |
| Sep 23, 2026 | $7.10 | +1348.98% | $36.72 | -12.13% | +1361.11% |
| Sep 22, 2026 | $- | $37.09 | -11.25% | - | |
| Sep 21, 2026 | $7.18 | +1365.31% | $37.00 | -11.46% | +1376.77% |
| Sep 18, 2026 | $7.16 | +1361.22% | $37.16 | -11.08% | +1372.30% |
| Sep 17, 2026 | $7.49 | +1428.57% | $37.36 | -10.60% | +1439.17% |
| Sep 16, 2026 | $7.81 | +1493.88% | $37.80 | -9.55% | +1503.43% |
| Sep 15, 2026 | $9.00 | +1736.73% | $37.98 | -9.12% | +1745.85% |
| Sep 14, 2026 | $11.63 | +2273.47% | $38.41 | -8.09% | +2281.56% |
| Sep 11, 2026 | $8.61 | +1657.14% | $38.41 | -8.09% | +1665.23% |
| Sep 10, 2026 | $6.18 | +1161.22% | $38.72 | -7.35% | +1168.57% |
Page 1 of 5